FDA
approval
· 2022-12-06
FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Dr.Reddys Laboratories Inc)
Summary
FDA approved a supplemental application for a buprenorphine and naloxone product from Dr. Reddy's Laboratories Inc. for the treatment of opioid use disorder (a …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)